These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36731366)

  • 41. Blocking NHE1 stimulates glioma tumor immunity by restoring OXPHOS function of myeloid cells.
    Hasan MN; Luo L; Ding D; Song S; Bhuiyan MIH; Liu R; Foley LM; Guan X; Kohanbash G; Hitchens TK; Castro MG; Zhang Z; Sun D
    Theranostics; 2021; 11(3):1295-1309. PubMed ID: 33391535
    [No Abstract]   [Full Text] [Related]  

  • 42. Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy.
    Tang L; Mei Y; Shen Y; He S; Xiao Q; Yin Y; Xu Y; Shao J; Wang W; Cai Z
    Int J Nanomedicine; 2021; 16():5811-5829. PubMed ID: 34471353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cancer Cell Membrane-Coated Nanosuspensions for Enhanced Chemotherapeutic Treatment of Glioma.
    Fan Y; Hao W; Cui Y; Chen M; Chu X; Yang Y; Wang Y; Gao C
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443689
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue.
    Zhang X; Li X; Hua H; Wang A; Liu W; Li Y; Fu F; Shi Y; Sun K
    Int J Nanomedicine; 2017; 12():5717-5732. PubMed ID: 28848349
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combination of levetiracetam and IFN-α increased temozolomide efficacy in MGMT-positive glioma.
    Ni XR; Guo CC; Yu YJ; Yu ZH; Cai HP; Wu WC; Ma JX; Chen FR; Wang J; Chen ZP
    Cancer Chemother Pharmacol; 2020 Dec; 86(6):773-782. PubMed ID: 33074386
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemosensitization of Temozolomide-Resistant Pediatric Diffuse Midline Glioma Using Potent Nanoencapsulated Forms of a N(3)-Propargyl Analogue.
    Heravi Shargh V; Luckett J; Bouzinab K; Paisey S; Turyanska L; Singleton WGB; Lowis S; Gershkovich P; Bradshaw TD; Stevens MFG; Bienemann A; Coyle B
    ACS Appl Mater Interfaces; 2021 Aug; 13(30):35266-35280. PubMed ID: 34310112
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Berberine and folic acid co-modified pH-sensitive cascade-targeted PTX-liposomes coated with Tween 80 for treating glioma.
    Yang C; Yang Z; Wang S; Chen J; Liu Q; Tianle Huang ; Hai L; Lu R; Wu Y
    Bioorg Med Chem; 2022 Sep; 69():116893. PubMed ID: 35752143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Micelle-templated, poly(lactic-
    Nabar GM; Mahajan KD; Calhoun MA; Duong AD; Souva MS; Xu J; Czeisler C; Puduvalli VK; Otero JJ; Wyslouzil BE; Winter JO
    Int J Nanomedicine; 2018; 13():351-366. PubMed ID: 29391794
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell Membrane Coated Nanoparticles: An Emerging Biomimetic Nanoplatform for Targeted Bioimaging and Therapy.
    Vijayan V; Uthaman S; Park IK
    Adv Exp Med Biol; 2018; 1064():45-59. PubMed ID: 30471025
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery.
    Zhang LY; Zhang JG; Yang X; Cai MH; Zhang CW; Hu ZM
    Curr Top Med Chem; 2020; 20(30):2789-2800. PubMed ID: 33076809
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hybrid Cell Membrane-Functionalized Biomimetic Nanoparticles for Targeted Therapy of Osteosarcoma.
    Cai JX; Liu JH; Wu JY; Li YJ; Qiu XH; Xu WJ; Xu P; Xiang DX
    Int J Nanomedicine; 2022; 17():837-854. PubMed ID: 35228800
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mild thermotherapy and hyperbaric oxygen enhance sensitivity of TMZ/PSi nanoparticles via decreasing the stemness in glioma.
    Zeng X; Wang Q; Tan X; Jia L; Li Y; Hu M; Zhang Z; Bai X; Zhu Y; Yang X
    J Nanobiotechnology; 2019 Apr; 17(1):47. PubMed ID: 30935403
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cancer cell membrane coated PLGA nanoparticles as biomimetic drug delivery system for improved cancer therapy.
    Li Y; Ke J; Jia H; Ren J; Wang L; Zhang Z; Wang C
    Colloids Surf B Biointerfaces; 2023 Feb; 222():113131. PubMed ID: 36646005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Co-delivery of cisplatin and rapamycin for enhanced anticancer therapy through synergistic effects and microenvironment modulation.
    Guo S; Lin CM; Xu Z; Miao L; Wang Y; Huang L
    ACS Nano; 2014 May; 8(5):4996-5009. PubMed ID: 24720540
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of CD133 Targeting Multi-Drug Polymer Micellar Nanoparticles for Glioblastoma - In Vitro Evaluation in Glioblastoma Stem Cells.
    Smiley SB; Yun Y; Ayyagari P; Shannon HE; Pollok KE; Vannier MW; Das SK; Veronesi MC
    Pharm Res; 2021 Jun; 38(6):1067-1079. PubMed ID: 34100216
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ligand-modified homologous targeted cancer cell membrane biomimetic nanostructured lipid carriers for glioma therapy.
    Chen M; Cui Y; Hao W; Fan Y; Zhang J; Liu Q; Jiang M; Yang Y; Wang Y; Gao C
    Drug Deliv; 2021 Dec; 28(1):2241-2255. PubMed ID: 34668811
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Strategies targeting tumor immune and stromal microenvironment and their clinical relevance.
    Hu M; Huang L
    Adv Drug Deliv Rev; 2022 Apr; 183():114137. PubMed ID: 35143893
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neural Cell Membrane-Coated Nanoparticles for Targeted and Enhanced Uptake by Central Nervous System Cells.
    Zhang N; Lin J; Chew SY
    ACS Appl Mater Interfaces; 2021 Dec; 13(47):55840-55850. PubMed ID: 34792341
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Binary blended co-delivery nanoparticles with the characteristics of precise pH-responsive acting on tumor microenvironment.
    Ye C; Li WJ; Yu HH; Feng QP; Wu X; Zhu YT; Hu MY; Xiang SY; Yu SQ
    Mater Sci Eng C Mater Biol Appl; 2020 Dec; 117():111370. PubMed ID: 32919698
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Study and evaluation of mechanisms of dual targeting drug delivery system with tumor microenvironment assays compared with normal assays.
    Gao H; Yang Z; Zhang S; Pang Z; Liu Q; Jiang X
    Acta Biomater; 2014 Feb; 10(2):858-67. PubMed ID: 24239900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.